Kuros Biosciences Ltd. | Cash Flow
Fiscal year is January-December. All values CHF Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
30,826.00
34,026.00
5,830.00
20,277.00
16,593.00
13,813
Depreciation, Depletion & Amortization
85.00
9.00
4.00
820.00
1,147.00
1,947
Other Funds
10,000.00
15,764.00
2,100.00
10,525.00
5,244.00
1,256
Funds from Operations
20,741.00
18,253.00
3,726.00
8,932.00
10,202.00
13,122
Changes in Working Capital
1,593.00
5,489.00
1,120.00
39.00
476.00
284
Net Operating Cash Flow
19,148.00
23,742.00
2,606.00
8,893.00
10,678.00
12,838
Capital Expenditures
92.00
20.00
-
50.00
1,573.00
Sale of Fixed Assets & Businesses
195.00
575.00
-
1,865.00
653.00
Purchase/Sale of Investments
-
-
-
-
15.00
Net Investing Cash Flow
103.00
555.00
-
1,815.00
905.00
Issuance/Reduction of Debt, Net
6,625.00
-
160.00
-
-
Net Financing Cash Flow
30,131.00
190.00
16,997.00
3,464.00
15,979.00
Net Change in Cash
11,262.00
22,912.00
14,354.00
3,571.00
4,304.00
Free Cash Flow
19,240.00
23,762.00
2,606.00
8,943.00
11,214.00
Change in Capital Stock
23,506.00
190.00
16,837.00
3,464.00
15,979.00
Exchange Rate Effect
176.00
85.00
37.00
43.00
91.00
Miscellaneous Funds
-
-
-
-
1.00
About Kuros Biosciences
View Profile
